Treatment of interstitial cystitis

Area of Science:

• Urology
• Nephrology
• Immunology

Background:

• Interstitial cystitis (IC) is a chronic condition causing bladder pain, urgency, and frequency.
• Symptoms mimic urinary tract infections but lack an infectious cause, rendering antibiotics ineffective.
• Severe IC significantly impairs patients' quality of life, particularly women.

Purpose of the Study:

• To review the diagnostic challenges and current treatment landscape for interstitial cystitis.
• To explore emerging therapeutic strategies for managing IC symptoms and improving patient outcomes.

Main Methods:

• Literature review of diagnostic criteria and treatment modalities for interstitial cystitis.
• Analysis of current pharmacologic treatments and their limited success.
• Examination of novel and investigational therapies for IC.

Main Results:

• IC diagnosis relies on patient history, physical examination, and cystoscopy.
• Established treatments like pentosan polysulfate, heparin, and dimethyl sulfoxide have shown limited efficacy.
• Investigational treatments including suplatast tosilate, resiniferatoxin, botulinum toxin, and gene therapy are under evaluation.

Conclusions:

• Effective treatment for IC remains a challenge due to its complex pathogenesis.
• Increased research into IC pathogenesis is crucial for developing more effective therapies.
• Advancements in understanding and treatment hold potential for improving the quality of life for IC patients.